Developing and evaluating online printed educational material on cancer and genetics.

Online genetic printed educational material for general practitioners (GPs): A double blind, randomised controlled trial of effectiveness.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22094

Enrollment

Registered

2012-03-10

Start date

2011-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer and genetics, general practice, family medicine, education, continuing medical education (CME), randomized controlled trial (RCT), printed educational material (PEM)

Interventions

The intervention consists of an online printed genetic educational material (PEM) on cancer and genetics written in collaboration with The Dutch College of General Practitioners (NHG).

Eligibility

Inclusion criteria

Inclusion criteria: To be eligible for the study, Dutch GPs outside the provinces of Noord Holland (METC approval from the VU University Medical Center acquired) and Limburg (METC approval acquired from the Maastricht University MUMC+) are required to work full- or part-time in a family practice setting. They are not required to comfortless use the internet, however a computer with internet access is necessary to access the online and login accessible genetic CME.

Exclusion criteria

Exclusion criteria: GPs are excluded if they are unwilling or unable to participate in either randomly assigned study group. Dutch GPs inside the provinces of Noord Holland and Limburg, because of logistic reasons and because we wished to evaluate participants knowledge based on the PEM intervention and not the live continuing educational meeting held in Noord Holland and Limburg. Validity of the test results could otherwise be diminished because of selection bias.

Design outcomes

Primary

Measure	Time frame
Knowledge is assessed immediately before the intervention, immediately after the intervention and 6 months later by mail linked to an online questionnaire.	—

Secondary

Measure	Time frame
Participants are also assessed for satisfaction of the online PEM immediately after the intervention. 6 months later the intervention group is further assessed for applicability of the acquired knowledge in daily genetic patient care.	—

Contacts

Public ContactElisa Houwink

Postbus 7057

e.houwink@vumc.nl+31 (0)20 4446446

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)